Showing results (651-660 of 6,709) with videos related to

Sort By:
Pageof 671
Oncotargets and Therapy|August 25, 2016
Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapyRadim Nemecek, Jitka Berkovcova, Lenka Radova, et al.
Oncotargets and Therapy|October 2, 2018
Apatinib combined with docetaxel as a salvage treatment for metastatic esophageal squamous cancer: a case reportLi-Jun Liang, Yi-Xuan Wen, You-You Xia, et al.
Oncotargets and Therapy|October 2, 2018
Combination of carcinoembryonic antigen with the American Joint Committee on Cancer TNM staging system in rectal cancer: a real-world and large population-based studyQi Liu, Peng Lian, Dakui Luo, et al.
Oncotargets and Therapy|October 2, 2018
Estrogen affects cell growth and IGF-1 receptor expression in renal cell carcinomaLijiang Sun, Zhemin Gao, Lei Luo, et al.
Oncotargets and Therapy|October 2, 2018
Elevated urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine and serum uric acid are associated with progression and are prognostic factors of colorectal cancerLingna Mao, Cheng Guo, Shu Zheng
Oncotargets and Therapy|October 2, 2018
Identification of the predictive genes for the response of colorectal cancer patients to FOLFOX therapyHengjun Lin, Xueke Qiu, Bo Zhang, et al.
Oncotargets and Therapy|September 21, 2018
MicroRNA 628 suppresses migration and invasion of breast cancer stem cells through targeting SOS1Chenghui Lin, Bin Gao, Xuemao Yan, et al.
Oncotargets and Therapy|September 21, 2018
Natural borneol is a novel chemosensitizer that enhances temozolomide-induced anticancer efficiency against human glioma by triggering mitochondrial dysfunction and reactive oxide species-mediated oxidative damageWen-Jian Liu, Yi-Bo Yin, Jing-Yi Sun, et al.
Oncotargets and Therapy|September 21, 2018
Clinical benefit of fulvestrant monotherapy in the multimodal treatment of hormone receptor and HER2 positive advanced breast cancer: a case seriesOrsolya Rusz, Renáta Kószó, Ágnes Dobi, et al.
Oncotargets and Therapy|September 21, 2018
Altered fractionation radiotherapy with or without chemotherapy in the treatment of head and neck cancer: a network meta-analysisYingyu Liu, Changgui Kou, Wei Bai, et al.
Pageof 671